Chennai: People whose immune systems mount an unusually aggressive early response to tuberculosis may be less likely to respond well to standard drug .

Dianthus achieved its NASDAQ listing last year via a merger with Magenta Therapeutics. The company is focused on development of a single drug candidate, DNTH-103, which targets the complement system, ...

The story of Q32 Bio, a company that develops therapeutics for inflammatory and autoimmune diseases, started two decades ago. That's when V. Michael Holers, MD, a University of Colorado School of ...

Vitamins C and E both support healthy skin and immune function in unique ways, and using them together may help you achieve better results in both areas.

A recent study by researchers from Institute of Science Tokyo unveils the molecular mechanisms explaining why some "stealth" drug coatings fail to evade the immune system. Using single-molecule atomic ...